These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26287748)

  • 21. An unhealthy disregard.
    Nat Med; 2010 Jun; 16(6):609. PubMed ID: 20526289
    [No Abstract]   [Full Text] [Related]  

  • 22. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
    Dusetzina SB; Mello MM
    N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 24. Adverse drug event reporting.
    Vaughan W
    Health Aff (Millwood); 2012 Aug; 31(8):1911. PubMed ID: 22869674
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of direct-to-consumer pharmaceutical advertising in patient consumerism.
    Wang B; Kesselheim AS
    Virtual Mentor; 2013 Nov; 15(11):960-5. PubMed ID: 24257088
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug firms back-pedal on direct advertising.
    Nature; 2005 Aug; 436(7053):910-1. PubMed ID: 16107811
    [No Abstract]   [Full Text] [Related]  

  • 27. Despite 2007 law requiring FDA hotline to be included in print drug ads, reporting of adverse events by consumers still low.
    Du D; Goldsmith J; Aikin KJ; Encinosa WE; Nardinelli C
    Health Aff (Millwood); 2012 May; 31(5):1022-9. PubMed ID: 22566442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ
    Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
    [No Abstract]   [Full Text] [Related]  

  • 29. Can DTCA bring you patients?
    Newman BY
    J Am Optom Assoc; 1999 Sep; 70(9):561. PubMed ID: 10547970
    [No Abstract]   [Full Text] [Related]  

  • 30. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
    Hall TS
    DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 32. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 33. Examining the FDA's oversight of direct-to-consumer advertising.
    Gahart MT; Duhamel LM; Dievler A; Price R
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.
    Frosch DL; Grande D; Tarn DM; Kravitz RL
    Am J Public Health; 2010 Jan; 100(1):24-32. PubMed ID: 19910354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Online healthcare advertising needs regulation.
    Masoni M; Guelfi MR; Gensini GF
    BMJ; 2011 Mar; 342():c5778. PubMed ID: 21372072
    [No Abstract]   [Full Text] [Related]  

  • 36. PLANNING IN THE FOOD AND DRUG ADMINISTRATION FOR REGULATION OF PRESCRIPTION DRUG ADVERTISING.
    SADUSK JF
    Curr Ther Res Clin Exp; 1965 May; 7():332-6. PubMed ID: 14286216
    [No Abstract]   [Full Text] [Related]  

  • 37. Oversight of opioid advertising in Canada remains lax despite new federal guidance.
    Webster P
    CMAJ; 2018 Jun; 190(23):E730-E731. PubMed ID: 29891483
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA tightens rules on advertising.
    Josefson D
    BMJ; 1997 Aug; 315(7106):447. PubMed ID: 9284658
    [No Abstract]   [Full Text] [Related]  

  • 39. Commercial speech, drugs, promotion and a tailored advertisement moratorium.
    Gilhooley M
    Health Matrix Clevel; 2011; 21(1):97-109. PubMed ID: 21847898
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea.
    Suh HS; Lee D; Kim SY; Chee DH; Kang HY
    Health Policy; 2011 Aug; 101(3):260-8. PubMed ID: 21705104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.